Payment overview · 2025
General Payments
$56.10
2 reported records · 1 companies
Healthcare provider profile · identity verified
Peter A Luongo, M.D.
Allopathic & Osteopathic Physicians|Internal Medicine · PARAMUS, NJ · NPI 1376520940
Verified facts
What the public records show
CMS Open Payments records show Peter A Luongo, M.D. received $56.10 in general payments during 2025 across 2 reported records.
Otsuka America Pharmaceutical, Inc. accounted for 100.0% of that reported general-payment amount.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | Unresolved — no canonical attribution shown | $56.10 | 100.0% | 2 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $56.10 | 2 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
Payment records were found, but the reported records did not identify a specific associated product for this analysis.
Public prescribing for products named in payments
There is no explicit payment-product set available for a Part D comparison.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 1587 | 442 |
| Amlodipine Besylate | Amlodipine Besylate | 1150 | 337 |
| Levothyroxine Sodium | Levothyroxine Sodium | 858 | 225 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 823 | 260 |
| Losartan Potassium | Losartan Potassium | 712 | 197 |
| Metformin Hcl | Metformin Hcl | 605 | 187 |
| Alprazolam | Alprazolam | 591 | 156 |
| Metoprolol Succinate | Metoprolol Succinate | 510 | 159 |
| Escitalopram Oxalate | Escitalopram Oxalate | 421 | 113 |
| Eliquis | Apixaban | 406 | 77 |
| Hydrochlorothiazide | Hydrochlorothiazide | 375 | 115 |
| Omeprazole | Omeprazole | 360 | 111 |
| Valsartan | Valsartan | 359 | 108 |
| Lisinopril | Lisinopril | 355 | 99 |
| Simvastatin | Simvastatin | 351 | 108 |
| Pantoprazole Sodium | Pantoprazole Sodium | 331 | 129 |
| Famotidine | Famotidine | 300 | 92 |
| Pravastatin Sodium | Pravastatin Sodium | 273 | 87 |
| Tamsulosin Hcl | Tamsulosin Hcl | 238 | 72 |
| Gabapentin | Gabapentin | 237 | 71 |
| Furosemide | Furosemide | 224 | 69 |
| Metoprolol Tartrate | Metoprolol Tartrate | 214 | 54 |
| Allopurinol | Allopurinol | 209 | 63 |
| Sertraline Hcl | Sertraline Hcl | 199 | 59 |
| Jardiance | Empagliflozin | 196 | 40 |
| Lorazepam | Lorazepam | 188 | 47 |
| Potassium Chloride | Potassium Chloride | 184 | 60 |
| Trazodone Hcl | Trazodone Hcl | 184 | 59 |
| Synthroid | Levothyroxine Sodium | 181 | 47 |
| Clopidogrel | Clopidogrel Bisulfate | 172 | 46 |
| Atenolol | Atenolol | 171 | 48 |
| Fluticasone Propionate | Fluticasone Propionate | 171 | 67 |
| Ramipril | Ramipril | 160 | 40 |
| Ezetimibe | Ezetimibe | 153 | 48 |
| Donepezil Hcl | Donepezil Hcl | 151 | 39 |
| Meloxicam | Meloxicam | 147 | 56 |
| Tramadol Hcl | Tramadol Hcl | 141 | 32 |
| Montelukast Sodium | Montelukast Sodium | 140 | 46 |
| Mirtazapine | Mirtazapine | 138 | 46 |
| Farxiga | Dapagliflozin Propanediol | 125 | 25 |
| Carvedilol | Carvedilol | 124 | 33 |
| Cefuroxime | Cefuroxime Axetil | 122 | 90 |
| Glimepiride | Glimepiride | 121 | 41 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 121 | 36 |
| Zolpidem Tartrate | Zolpidem Tartrate | 120 | 39 |
| Ozempic | Semaglutide | 119 | 33 |
| Metformin Hcl Er | Metformin Hcl | 117 | 39 |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 108 | 32 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 104 | 21 |
| Torsemide | Torsemide | 102 | 29 |
| Azithromycin | Azithromycin | 101 | 76 |
| Citalopram Hbr | Citalopram Hydrobromide | 101 | 27 |
| Enalapril Maleate | Enalapril Maleate | 101 | 24 |
| Clonazepam | Clonazepam | 100 | 22 |
| Irbesartan | Irbesartan | 100 | 28 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 96 | 37 |
| Warfarin Sodium | Warfarin Sodium | 94 | suppressed |
| Celecoxib | Celecoxib | 93 | 41 |
| Finasteride | Finasteride | 92 | 30 |
| Memantine Hcl | Memantine Hcl | 90 | 25 |
| Methylprednisolone | Methylprednisolone | 87 | 65 |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 85 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 82 | 23 |
| Duloxetine Hcl | Duloxetine Hcl | 80 | 28 |
| Prednisone | Prednisone | 78 | 28 |
| Nebivolol Hcl | Nebivolol Hcl | 77 | 25 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 74 | 24 |
| Xarelto | Rivaroxaban | 74 | 25 |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 73 | suppressed |
| Hydrocortisone | Hydrocortisone | 73 | 38 |
| Spironolactone | Spironolactone | 73 | 23 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 69 | 45 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 68 | 20 |
| Quetiapine Fumarate | Quetiapine Fumarate | 68 | 22 |
| Diazepam | Diazepam | 67 | 16 |
| Januvia | Sitagliptin Phosphate | 67 | 18 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 67 | 21 |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 66 | 19 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 65 | 16 |
| Latanoprost | Latanoprost | 59 | 15 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 59 | 17 |
| Mupirocin | Mupirocin | 54 | 39 |
| Doxazosin Mesylate | Doxazosin Mesylate | 50 | 15 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 49 | suppressed |
| Myrbetriq | Mirabegron | 48 | suppressed |
| Bupropion Xl | Bupropion Hcl | 46 | 14 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 45 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 45 | 18 |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 44 | 22 |
| Divalproex Sodium | Divalproex Sodium | 44 | suppressed |
| Ibandronate Sodium | Ibandronate Sodium | 43 | 14 |
| Levetiracetam | Levetiracetam | 43 | 12 |
| Repaglinide | Repaglinide | 43 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 42 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 42 | 18 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 41 | 12 |
| Paroxetine Hcl | Paroxetine Hcl | 41 | 16 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 40 | 16 |
| Chlorthalidone | Chlorthalidone | 39 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 39 | 16 |
| Alendronate Sodium | Alendronate Sodium | 38 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 38 | 14 |
| Amoxicillin | Amoxicillin | 37 | 22 |
| Bydureon Bcise | Exenatide Microspheres | 37 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 37 | 11 |
| Fenofibrate | Fenofibrate Nanocrystallized | 37 | 11 |
| Fluoxetine Hcl | Fluoxetine Hcl | 37 | 11 |
| Raloxifene Hcl | Raloxifene Hcl | 37 | suppressed |
| Ketoconazole | Ketoconazole | 36 | 25 |
| Meclizine Hcl | Meclizine Hcl | 36 | 18 |
| Oseltamivir Phosphate | Oseltamivir Phosphate | 36 | 32 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 35 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 34 | 22 |
| Colchicine | Colchicine | 34 | 16 |
| Fluocinonide | Fluocinonide | 34 | 18 |
| Temazepam | Temazepam | 34 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 33 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 32 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 32 | suppressed |
| Nystatin | Nystatin | 32 | 15 |
| Buspirone Hcl | Buspirone Hcl | 31 | suppressed |
| Candesartan Cilexetil | Candesartan Cilexetil | 31 | suppressed |
| Fenofibrate | Fenofibrate | 31 | suppressed |
| Glipizide | Glipizide | 31 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 31 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 31 | 16 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 30 | 28 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 30 | 13 |
| Verapamil Er | Verapamil Hcl | 30 | suppressed |
| Nifedipine Er | Nifedipine | 28 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 28 | 20 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 28 | 11 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 28 | 11 |
| Azelastine Hcl | Azelastine Hcl | 27 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 27 | 12 |
| Lidocaine | Lidocaine | 27 | 12 |
| Linzess | Linaclotide | 27 | suppressed |
| Methimazole | Methimazole | 27 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 27 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 27 | suppressed |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 26 | suppressed |
| Mounjaro | Tirzepatide | 26 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 26 | 26 |
| Scopolamine | Scopolamine | 26 | suppressed |
| Trintellix | Vortioxetine Hydrobromide | 26 | suppressed |
| Glipizide Er | Glipizide | 25 | suppressed |
| Irbesartan-Hydrochlorothiazide | Irbesartan/Hydrochlorothiazide | 25 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 24 | 22 |
| Telmisartan | Telmisartan | 24 | suppressed |
| Eszopiclone | Eszopiclone | 23 | suppressed |
| Loperamide | Loperamide Hcl | 23 | suppressed |
| Olanzapine | Olanzapine | 23 | suppressed |
| Cefdinir | Cefdinir | 22 | 19 |
| Sucralfate | Sucralfate | 22 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 22 | 20 |
| Tresiba Flextouch U-200 | Insulin Degludec | 22 | suppressed |
| Lansoprazole | Lansoprazole | 21 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 21 | suppressed |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 21 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 21 | suppressed |
| Cephalexin | Cephalexin | 20 | 17 |
| Lovastatin | Lovastatin | 20 | suppressed |
| Pregabalin | Pregabalin | 20 | suppressed |
| Ssd | Silver Sulfadiazine | 20 | suppressed |
| Trulicity | Dulaglutide | 20 | suppressed |
| Mesalamine | Mesalamine | 19 | suppressed |
| Tradjenta | Linagliptin | 19 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 18 | suppressed |
| Cholestyramine | Cholestyramine (With Sugar) | 18 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 18 | 13 |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 17 | 11 |
| Gemfibrozil | Gemfibrozil | 17 | suppressed |
| Amlodipine-Valsartan | Amlodipine Besylate/Valsartan | 16 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 16 | suppressed |
| Comfort Ez Pro Safety Pen Ndl | Pen Needle, Diabetic, Safety | 16 | suppressed |
| Dapagliflozin | Dapagliflozin Propanediol | 16 | suppressed |
| Novofine Autocover | Pen Needle, Diabetic, Safety | 16 | suppressed |
| Potassium Citrate Er | Potassium Citrate | 16 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 16 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 16 | suppressed |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 15 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 15 | suppressed |
| Livalo | Pitavastatin Calcium | 15 | suppressed |
| Ondansetron Odt | Ondansetron | 15 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 15 | suppressed |
| Dutasteride | Dutasteride | 14 | suppressed |
| Fenofibrate | Fenofibrate,micronized | 14 | suppressed |
| Ranolazine Er | Ranolazine | 14 | suppressed |
| Aripiprazole | Aripiprazole | 13 | suppressed |
| Carbidopa-Levodopa Er | Carbidopa/Levodopa | 13 | suppressed |
| Dexlansoprazole Dr | Dexlansoprazole | 13 | suppressed |
| Epinephrine | Epinephrine | 13 | suppressed |
| Methotrexate | Methotrexate Sodium | 13 | suppressed |
| Naproxen | Naproxen | 13 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 13 | suppressed |
| Risedronate Sodium | Risedronate Sodium | 13 | suppressed |
| Risperidone | Risperidone | 13 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 12 | suppressed |
| Digoxin | Digoxin | 12 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 12 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 12 | suppressed |
| Lagevrio (Eua) | Molnupiravir | 12 | 11 |
| Metronidazole | Metronidazole | 12 | suppressed |
| Prochlorperazine Maleate | Prochlorperazine Maleate | 12 | suppressed |
| Silver Sulfadiazine | Silver Sulfadiazine | 12 | suppressed |
| Topiramate | Topiramate | 12 | suppressed |
| Ultra-Fine Nano Pen Needle | Pen Needle, Diabetic | 12 | suppressed |
| Advair Diskus | Fluticasone Propion/Salmeterol | 11 | suppressed |
| Amantadine | Amantadine Hcl | 11 | suppressed |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 11 | suppressed |
| Ciclopirox | Ciclopirox Olamine | 11 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 11 | suppressed |
| Imitrex | Sumatriptan Succinate | 11 | suppressed |
| Lactulose | Lactulose | 11 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 11 | suppressed |
| Saxagliptin Hcl | Saxagliptin Hcl | 11 | suppressed |
| Tobramycin-Dexamethasone | Tobramycin/Dexamethasone | 11 | suppressed |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 11 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $56.10 · 2 records | Otsuka America Pharmaceutical, Inc. | — | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error